Table 1.

Clinical findings and patient histories

UPN/sexGenotypePositive family historyClinical abnormalitiesAge at diagnosisAge at transplantation
275/F V-ATPase* Yes Hepatomegaly, anemia 1 mo 5.5 mo 
292/F V-ATPase* No Visual impairment, hypocalcemic convulsions, hepatosplenomegaly, anemia, thrombocytopenia 2 mo 6 mo 
302/F V-ATPase* No Visual impairment, hypocalcemic convulsions, hepatosplenomegaly, anemia 1 mo 3.5 mo 
303/F V-ATPase* No Visual impairment, hepatosplenomegaly, hypocalcemia, anemia 0.5 mo 2 mo 
323/F ND Yes Hypocalcemic convulsions At birth 1.5 mo  
332/M V-ATPase* No Hypocalcemic convulsions, splenomegaly 0.5 mo 5 mo  
364/F ND No Visual impairment, anemia, thrombocytopenia 5 mo 6 mo 
UPN/sexGenotypePositive family historyClinical abnormalitiesAge at diagnosisAge at transplantation
275/F V-ATPase* Yes Hepatomegaly, anemia 1 mo 5.5 mo 
292/F V-ATPase* No Visual impairment, hypocalcemic convulsions, hepatosplenomegaly, anemia, thrombocytopenia 2 mo 6 mo 
302/F V-ATPase* No Visual impairment, hypocalcemic convulsions, hepatosplenomegaly, anemia 1 mo 3.5 mo 
303/F V-ATPase* No Visual impairment, hepatosplenomegaly, hypocalcemia, anemia 0.5 mo 2 mo 
323/F ND Yes Hypocalcemic convulsions At birth 1.5 mo  
332/M V-ATPase* No Hypocalcemic convulsions, splenomegaly 0.5 mo 5 mo  
364/F ND No Visual impairment, anemia, thrombocytopenia 5 mo 6 mo 

ND indicates not determined.

*

Mutations in the a3 subunit of the vacuolar H+-ATPase described in Kornak et al.3 

Close Modal

or Create an Account

Close Modal
Close Modal